328 related articles for article (PubMed ID: 28498475)
1. Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
Liu Y; Murray-Stewart T; Casero RA; Kagiampakis I; Jin L; Zhang J; Wang H; Che Q; Tong H; Ke J; Jiang F; Wang F; Wan X
Int J Oncol; 2017 Jun; 50(6):2011-2023. PubMed ID: 28498475
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer.
Fan L; Huang C; Li J; Gao T; Lin Z; Yao T
Int J Mol Med; 2018 Oct; 42(4):2247-2259. PubMed ID: 30015920
[TBL] [Abstract][Full Text] [Related]
3. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
[TBL] [Abstract][Full Text] [Related]
4. The Roles of HK2 on Tumorigenesis of Cervical Cancer.
Liu C; Wang X; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819871306. PubMed ID: 31530094
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
6. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microRNA-155 sensitizes lung cancer cells to irradiation via suppression of HK2-modulated glucose metabolism.
Lv X; Yao L; Zhang J; Han P; Li C
Mol Med Rep; 2016 Aug; 14(2):1332-8. PubMed ID: 27315591
[TBL] [Abstract][Full Text] [Related]
8. Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein.
Lee SA; Ho C; Troxler M; Lin CY; Chung SH
Viruses; 2021 Mar; 13(3):. PubMed ID: 33800513
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
10. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
11. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
Hui L; Zhang J; Guo X
Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
[TBL] [Abstract][Full Text] [Related]
12. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
13. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
[TBL] [Abstract][Full Text] [Related]
14. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.
Zheng M; Wu C; Yang K; Yang Y; Liu Y; Gao S; Wang Q; Li C; Chen L; Li H
Pharmacol Res; 2021 Feb; 164():105367. PubMed ID: 33307221
[TBL] [Abstract][Full Text] [Related]
15. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.
Zhu D; Shen H; Tan S; Hu Z; Wang L; Yu L; Tian X; Ding W; Ren C; Gao C; Cheng J; Deng M; Liu R; Hu J; Xi L; Wu P; Zhang Z; Ma D; Wang H
Mol Ther; 2018 Oct; 26(10):2443-2455. PubMed ID: 30241742
[TBL] [Abstract][Full Text] [Related]
18. Viral
Hoppe-Seyler K; Honegger A; Bossler F; Sponagel J; Bulkescher J; Lohrey C; Hoppe-Seyler F
Oncotarget; 2017 Dec; 8(63):106342-106351. PubMed ID: 29290953
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
20. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
